Our Company

Meet the Leadership Team

Marzio Pozzuoli

 Chief Executive Officer
Toronto, Canada

Phil Levy

Phil Levy, P. Eng.

 Chief Technology Officer

Toronto, Canada

Dr. Keith Thompson, MD, FCFP

 Chief Medical Officer

Toronto, Canada

Dr Naresh Vempala

Dr. Naresh Vempala, Ph.D.

Director of Research
Toronto, Canada

Roberto Liddi

Dr. Roberto Liddi, Ph.D.

VP of Regulatory Affairs and Compliance
Oxford,
       United Kingdom       

Roy Dalton

Roy Dalton, CPA, CA

Chief Financial Officer

Toronto, Canada

Chris Lin

Chris Lin

Chief Marketing Officer

Toronto, Canada

Michael Keefe

Michael Keefe

VP of Global Sales

Toronto, Canada

Sarah Banavage

Director of Sales & Partnerships, EMEA and LATAM  

Amsterdam, Netherlands

Dr. Aileen Zhou  Ph.D., BASc

Director of Regulatory Affairs 

Toronto, Canada

Dr Hu Jun

Dr. Hu Jun, PhD.

General Manager
(China Region)
Hangzhou, China

Dr. Paul Zheng, Ph.D.

Chief Researcher

Toronto, Canada

John Cockcroft

Prof. John Cockcroft

Scientific Advisor
New York, United States

Dr. Matthew Cooper

Scientific Advisor
Minnesota, United States

Dr. Kang Lee, Ph.D.

Chief Science Officer Emeritus (2015-2021) Toronto, Canada

GET IN TOUCH

Quick Links

Technology

Research

DeepAffex®

Anura®

DFX Live™

News

Company

Privacy Policy

Terms of Use

Cookie Policy

Security & Compliance

  • Twitter
  • Facebook
  • Linkedin
  • Youtube

Corporate Headquarters

NuraLogix Corporation

250 University Avenue, Suite 209

Toronto, ON, Canada M5H 3E5

Email: info@nuralogix.ai

Phone: +1 (416) 368-6000

In the United States, this product is for Investigational Use Only. The performance characteristics of this product have not been established.

© Copyright NuraLogix Corporation

Regional Offices

North America
sales-na@nuralogix.ai

Latin America and EMEA (Europe, Middle East and Africa)
sales-emea@nuralogix.ai

APAC (Asia-Pacific)
sales-apac@nuralogix.ai

China (Mainland)
sales-china@nuralogix.ai

Marzio Pozzuoli

Chief Executive Officer

Marzio is an experienced and passionate technology entrepreneur with over 30 years of product development experience. Prior to NuraLogix, Marzio founded RuggedCom, a communications networking company, which he took from startup to acquisition and was named the CVCA Entrepreneur of The Year for 2013.

Phil Levy

Phil Levy, P. Eng.

Chief Technology Officer

Phil is the CTO at NuraLogix and is a veteran leader of technology product development. He brings over 25 years of direct experience with diverse, high-performance R&D teams creating breakthrough technologies.

Dr. Keith Thompson, MD, FCFP

Chief Medical Officer

 

Dr. Thompson obtained his Doctorate, Doctor of Medicine, from the University of Western Ontario. He is Fellowship Canadian College Family Practice and Adjunct Faculty Dept Family Medicine UWO, involved in Virtual Care research. He is BCMAS (Board Certified Medical Affairs Specialist) and is working Group Lead for both IEEE SA and WONCA e-Health.

Dr Naresh Vempala

Dr. Naresh Vempala, Ph.D.

Director of Research

Dr. Vempala has a Ph.D. in cognitive science minoring in AI, an M.S. in computer science from the Center for Advanced Computer Studies, University of Louisiana at Lafayette, and an M.S. in civil engineering from Mississippi State University. He has over 20 years of experience in industry and academia.

Roberto Liddi

Dr. Roberto Liddi, Ph.D.

VP of Regulatory Affairs and Compliance

Experienced regulatory professional with a demonstrated history of working in the medical device manufacturing industry. Skilled in U.S. Food and Drug Administration (FDA) Regulations, Regulatory Strategy, Corrective and Preventive Action (CAPA), Quality Auditing, Risk Management and CE marking. He has experience in a variety of medical device industries, spanning from orthopaedic device, to neurosurgical and3D printed implantable devices, IVD and Software as Medical Device. Strong healthcare services professional with a Doctorate in Biological Sciences focused in Human Biology and Immunolgy from Università degli Studi di Bari. Previous member of Advisory Group to the European Commission and current Chair of the Digital Health Group – ABHI. Caldicott Guardian and DPO listed. Member of the NHS NIHR D4D Committee

Roy Dalton

Roy Dalton, CPA, CA

Chief Financial Officer

Roy Dalton joined Nuralogix in 2023 and is the company’s Chief Financial Officer. Mr. Dalton brings to the company more than 30 years of financial experience with both public and private hardware and software technology companies. Mr. Dalton was the CFO at RuggedCom, a communications networking company, from 2004 until 2012, until its acquisition by Siemens.

Chris Lin

Chris Lin

Chief Marketing Officer

Chris Lin joined NuraLogix in 2018 as CMO, he leads the company’s brand, product strategy, go-to-market strategy and demand generation. Chris held sales and marketing leadership positions at GE, SAP, Microsoft, IBM, Dell, and Lenovo.

Michael Keefe

Michael Keefe

VP of Global Sales

Michael Keefe is the Vice President, Global Sales at NuraLogix. Michael brings more than 25 years of sales, strategy and product innovation experience to NuraLogix, previously working with clients including Akzo Nobel/Organon (Merck), Johns Hopkins, US Army TATRC and MediResource to expand sales and bring new products to market.

Sarah Banavage

Director of Sales & Partnerships, EMEA and LATAM

As the Director of Sales & Partnerships for EMEA and LATAM at NuraLogix, Sarah Banavage brings a wealth of experience from global leaders like GFI Software, Paramount International, FUGA, and BlueConic. She specializes in driving strategic initiatives, managing client relationships, and optimizing digital operational processes. Sarah‘s efforts are central to forging key partnerships and driving sales growth, ensuring the successful reach of NuraLogix’s innovative AI solutions.

Dr. Aileen Zhou, PhD, BASc

Director of Regulatory Affairs

 

Aileen brings over a decade of experience in regulatory affairs working with innovative medical devices in domestic and global markets. Prior to joining NuraLogix, Aileen held several regulatory leadership positions, including Senior Manager, Regulatory Affairs at Centre for Commercialization of Regenerative Medicine (CCRM) and Project Manager, Regulatory Affairs at Synaptive Medical, a global medical device and technology company. In these roles, Aileen provided pivotal regulatory leadership throughout the product lifecycle and played a leading role in regulatory filings and product registrations in the U.S., Canada, EU, Australia, and other international markets. Prior to that, Aileen held several positions in scientific and regulatory affairs at Induce Biologics, an innovative tissue engineering company. During her tenure, Aileen single-handedly built up the entire regulatory asset and led several successful interactions with Health Canada and the U.S. FDA.

Aileen earned a PhD with a focus in biotechnology as an NSERC scholar and a Bachelor of Applied Science in biomedical engineering, both from the University of Toronto. She is an active member and contributing author of Regulatory Affairs Professional Society.

Dr Hu Jun

Dr. Hu Jun, PhD.

General Manager (China Region)

Dr. Hu is the GM of our WOFE, NuraLogix (Hangzhou) Artificial Intelligence Co., Ltd.. He holds a PhD in mechanical engineering and has over 20 years of technical, sales and management experience. Prior NuraLogix, Dr. Hu was GM of RuggedCom China.

Dr. Paul Zheng, PhD.

Chief Researcher

Dr. Pu Zheng (Paul) is the Co-founder and Senior Researcher of NuraLogix. He holds a PhD. degree in emotional psychology and has over 8 years of experience in designing and conducting behavioural and neuroimaging psychology experiments.

Prof. John Cockcroft

Scientific Advisor

Professor Cockcroft is visiting Professor in the Dept of Advanced Cardiology at Columbia University Medical Center, New York where he is researching haemodynamics in patients with left ventricular assist devices (LVAD’s) in terms of the vascular complications seen in this group in order to improve their cardiovascular outcomes. He has published over 350 peer-reviewed articles in the field of hypertension and cardiovascular disease.

Matthew M. Cooper, MD MBA FACS FAsMA FCAMA

Scientific Advisor

Dr. Cooper served as Vice President Medical Affairs, Corporate Health, & Safety for 3M Health Care. He is a Diplomat of the American Boards of Thoracic Surgery and Surgery, and a Fellow of the American College of Surgeons, the Aerospace Medical Association, and the Civil Aviation Medical Association. He is a graduate of Franklin & Marshall College, New York University School of Medicine, and Spears School of Business, Oklahoma State University.  In addition to Residencies and Chief Residencies in General Surgery and Thoracic Surgery, he also completed a Medical Staff Fellowship in the Surgery Branch of the NHLBI and a Fellowship in Pediatric Cardiothoracic Surgery.

Dr. Cooper’s research has included pioneering methods of immunosuppression for primate cardiac xenograft transplantation. He is an expert in Aviation Physiology, a Special Consultant to the Federal Air Surgeon, a leader in the application of aviation-based safety culture to health care.

Dr. Kang Lee, PhD.

Chief Science Officer Emeritus (2015-2021)

Dr. Lee was one of the three Co-founders of NuraLogix. He served as Chief Science Officer from the company’s founding in 2015 until September 1st of 2021. During his time at NuraLogix Dr. Lee helped pioneer Transdermal Optical Imaging (TOI™) and its use in health and wellness applications across multiple industries. He co-authored 11 patents along with numerous scientific papers and publications on the science of TOI and its many uses for healthcare.

Dr. Lee is a professor and Tier 1 Canada Research Chair in developmental neuroscience at the University of Toronto.